Ball from Deflategate game heads to auction for $25K
The price tag for a football from last season’s infamous AFC Championship game between the Colts and Patriots has been inflated.
Bloomberg News
Articles
Hill-Rom to acquire medical supplies firm for $2 billion
The acquisition lets Hill-Rom, a maker of hospital supplies for wound care and respiratory health, delve further into the market for diagnostic supplies for physicians and emergency responders
Potential deal drama heats up among five health insurers
The biggest U.S. providers—UnitedHealth Group Inc., Anthem Inc., Aetna Inc., Cigna Corp. and Humana Inc.—are all looking at possible combinations. Indianapolis-based Anthem is considering a takeover of Cigna or Humana, a person familiar with the matter said.
Gap to shut down 175 stores in turnaround bid
About 175 underperforming Gap stores will close in North America as part of a comeback plan for the business, which has posted sales declines for five straight quarters and lagged behind its sister chain Old Navy.
Hudson’s Bay moves closer to IPO after $2.6B acquisition
The purchase of Metro AG’s Galeria Kaufhof stores is Hudson’s Bay’s first under its joint venture with Simon Property Group, marking a new era of real-estate fueled growth as retailers try to squeeze more value from their property.
Startup aims to upend diabetes care with matchstick-size implant
Intarcia Therapeutics Inc. is betting its matchstick-size pump could take market share from Eli Lilly and Co., AstraZeneca Plc and Novo Nordisk A/S.
Obama’s fast-track trade bill scuttled by House Democrats
Democrats handed President Barack Obama an embarrassing defeat on his trade agenda, blocking final passage of fast-track negotiating authority just hours after he made a rare visit to Capitol Hill to seek their support.
Biotech with unproven Alzheimer’s drug now worth billions
Axovant Sciences Ltd., a company without a finished product or a dime of sales, has an almost $3 billion valuation after its public-market debut. The IPO shows the staggering potential for any company that can develop a successful Alzheimer’s treatment.
EPA seen siding with engine makers in truck efficiency rules
The Obama administration is poised to deliver a victory to engine makers at the expense of truck manufacturers such as Cummins Inc. in the next stage of the U.S. government’s plan to tackle climate change.
Federal data hack far bigger than originally thought
Already considered one of the largest thefts of U.S. government personnel data in history, investigators now estimate that it may include data on as many as 14 million people, including every federal employee.
Soaring Subaru closing in on difficult crossroads
Subaru, which has thousands of workers in Indiana, has never seen so much demand from car buyers. But making big moves to boost output could hurt the very thing that customers love about the automaker—its smaller size.
Eli Lilly says it has ‘no intention’ to spin off animal health unit
Eli Lilly stock rose 5.4 percent per share on Tuesday, its biggest daily increase since March 2009, after Elanco President Jeffrey Simmons was asked if Lilly might one day shed the unit in an initial public offering.
Speculation grows over possible Humana acquisition
Humana Inc. has pulled out of a major health care conference and said it will not comment on rumors of a merger, actions that will likely fuel Wall Street speculation that the insurer is part of a developing deal. Anthem Inc. is a possible suitor.
Lilly to launch Lantus biosimilar in Europe in third quarter
Indianapolis-based Eli Lilly and Co. plans to introduce its version of Sanofi’s Lantus insulin for diabetes in Europe in the third quarter, said Enrique Conterno, the president of Lilly Diabetes.
Female libido drug nears approval with FDA panel’s backing
An experimental pill to treat low sexual desire in women moved closer to becoming the first such drug to be sold in the U.S. after regulatory advisers backed its approval.
U.S. steelmakers file trade case over imports from China
Steelmakers including Indiana-based Steel Dynamics Inc. filed a trade complaint alleging that imports of corrosion-resistant metal from China and four other countries are being sold in the U.S. at unfairly low prices.
Charter’s cable buy faces easier road than Comcast’s
Charter Communications Inc.’s proposed purchase of Time Warner Cable Inc. faces fewer hurdles to U.S. regulatory approval than Comcast Corp.’s ill-fated bid to buy the No. 2 cable provider.
Lilly to market euro bonds as low rates lure U.S. firms
The drugmaker plans to sell 2.1 billion euros ($2.3 billion) of securities in three parts, according to a person familiar with the matter who asked not to be identified.
Indiana paying $71M more on Lucas Oil Stadium debt
The Indiana Finance Authority is paying about $71 million to Goldman Sachs Group Inc. to end an interest-rate swap as part of a bond sale to refinance debt for Lucas Oil Stadium. An additional $34.7 million is being paid for the Indiana Convention Center.
Patriots’ attorney says NFL’s deflation report is ‘incorrect’
The New England Patriots’ attorney said the conclusions of the Wells Report, which led to a four-game suspension for quarterback Tom Brady and $1 million fine for the team, are “incomplete, incorrect and lack context.”